Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers <i>In vitro</i> and in an Animal Model

Ursula Reusch, Lawrence G. Lum, Pamela A. Davol et al.|Clinical Cancer Research|2006

Cited by 106